FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos Gamazo

Research Profile

Disorders

Brucellosis

Living Beings

Chemicals & Drugs

Objects

Concepts & Ideas

Particle Size

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
M Sánchez-Martínez; G Quincoces; C Caicedo; R da Costa Martins; Carlos Gamazo; Juan M Irache; Iván Peñuelas
[Radiolabeling and biodistribution studies of polymeric nanoparticles as adjuvants for ocular vaccination against brucellosis].
Ana Isabel Camacho; Juan Manuel Irache; Carlos Gamazo
Recent progress towards development of a Shigella vaccine.
Juliana De Souza Rebouças; María L Sanz; Juan Manuel Irache; Ana I Camacho; Victoria Del Pozo; Irene Esparza; Marta Ferrer; Carlos Gamazo
Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos Gamazo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M Sánchez-Martínez; G Quincoces; C Caicedo; R da Costa Martins; Carlos Gamazo; Juan M Irache; Iván Peñuelas
[Radiolabeling and biodistribution studies of polymeric nanoparticles as adjuvants for ocular vaccination against brucellosis].
Revista española de medicina nuclear e imagen molecular 2013;32(2):92-7.
2013: Ana Isabel Camacho; Juan Manuel Irache; Carlos Gamazo
Recent progress towards development of a Shigella vaccine.
Expert review of vaccines 2013;12(1):43-55.
2012: Juliana De Souza Rebouças; María L Sanz; Juan Manuel Irache; Ana I Camacho; Victoria Del Pozo; Irene Esparza; Marta Ferrer; Carlos Gamazo
Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;82(2):241-9.
2012: Raquel Da Costa Martins; Carlos Gamazo; Iván Peñuelas; María Sánchez-Martínez; Montserrat Barberán; Juan M Irache
Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2012;162(3):553-60.
2012: Edurne Imbuluzqueta; Sandrine Lemaire; Françoise Van Bambeke; Jaume Veciana; Nora Ventosa; Elisa Elizondo; Carlos Gamazo; María J Blanco-Prieto
Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.
The Journal of antimicrobial chemotherapy 2012;67(9):2158-64.
2012: Juliana De Souza Rebouças; Irene Esparza; Marta Ferrer; Juan Manuel Irache; María Luisa Sanz; Carlos Gamazo
Nanoparticulate adjuvants and delivery systems for allergen immunotherapy.
Journal of biomedicine & biotechnology 2012;2012():474605.
2011: A I Camacho; J de Souza; Juan M Irache; M Pardo-Ros; S Sánchez-Gómez; Carlos Gamazo
Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice.
Vaccine 2011;29(46):8222-9.
2011: A I Camacho; R Da Costa Martins; J de Souza; I Esparza; Juan M Irache; Juan José Lasarte; C Mansilla; I Tamayo; Carlos Gamazo
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators.
Vaccine 2011;29(41):7130-5.
2011: Juan M Irache; Carlos Gamazo; Maite Agüeros; Irene Esparza; Socorro Espuelas
Nanomedicine: novel approaches in human and veterinary therapeutics.
Veterinary parasitology 2011;180(1-2):47-71.
2011: Edurne Imbuluzqueta; Elisa Elizondo; Carlos Gamazo; Evelyn Moreno-Calvo; Jaume Veciana; Nora Ventosa; María J Blanco-Prieto
Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
Acta biomaterialia 2011;7(4):1599-608.
2011: Elisa Elizondo; Santiago Sala; Edurne Imbuluzqueta; David González; María J Blanco-Prieto; Carlos Gamazo; Nora Ventosa; Jaume Veciana
High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide.
Pharmaceutical research 2011;28(2):309-21.
2010: I Tamayo; Juan M Irache; C Mansilla; Javier Ochoa-Repáraz; Juan José Lasarte; Carlos Gamazo
Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation.
Clinical and vaccine immunology : CVI 2010;17(9):1356-62.
2010: Alina S Porfire; Virginia Zabaleta; Carlos Gamazo; Sorin E Leucuta; Juan M Irache
Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.
International journal of pharmaceutics 2010;390(1):37-44.
2010: Raquel Da Costa Martins; Juan M Irache; José María Blasco; M Pilar Muñoz; Clara María Marín; M Jesús Grilló; M Jesús De Miguel; Montserrat Barberán; Carlos Gamazo
Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
Vaccine 2010;28(17):3038-46.
2010: Juan M Irache; SALMAN Hesham; Sara Gomez; Socorro Espuelas; Carlos Gamazo
Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination.
Frontiers in bioscience (Scholar edition) 2010;2():876-90.
2010: Edurne Imbuluzqueta; Carlos Gamazo; Javier Ariza; Maria J Blanco-Prieto
Drug delivery systems for potential treatment of intracellular bacterial infections.
Frontiers in bioscience : a journal and virtual library 2010;15():397-417.
2009: Carlos Gamazo; Juan Manuel Irache
New adjuvants: from empiricism to science.
Expert review of vaccines 2009;8(10):1333-7.
2009: Sara Gómez; Carlos Gamazo; Beatriz San Roman; Alicia Grau; Socorro Espuelas; Marta Ferrer; María L Sanz; Juan M Irache
A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne.
Journal of immunological methods 2009;348(1-2):1-8.
2009: SALMAN Hesham; Juan M Irache; Carlos Gamazo
Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
Vaccine 2009;27(35):4784-90.
2009: Raquel Da Costa Martins; Carlos Gamazo; Juan M Irache
Design and influence of gamma-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;37(5):563-72.
2009: Beatriz San Román; Juan M Irache; Sara Gómez; Carlos Gamazo; Socorro Espuelas
Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
International archives of allergy and immunology 2009;149(2):111-8.
2008: SALMAN Hesham; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.
Pharmaceutical research 2008;25(12):2859-68.
2008: Sara Gómez; Carlos Gamazo; Beatriz San Roman; Marta Ferrer; María L Sanz; Socorro Espuelas; Juan M Irache
Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(3):711-7.
2008: Beatriz San Román; Juan M Irache; Sara Gómez; Nicolas Tsapis; Carlos Gamazo; María Socorro Espuelas
Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(1):98-108.
2008: Juan M Irache; SALMAN Hesham; Carlos Gamazo; Socorro Espuelas
Mannose-targeted systems for the delivery of therapeutics.
Expert opinion on drug delivery 2008;5(6):703-24.
2008: Maite Estevan; Carlos Gamazo; Fernando Martínez-Galan; Juan M Irache
Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.
AAPS PharmSciTech 2008;9(4):1063-9.
2007: SALMAN Hesham; Carlos Gamazo; Maite Agüeros; Juan M Irache
Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.
Vaccine 2007;25(48):8123-32.
2007: Carlos Gamazo; Sandra Prior; María Concepción Lecároz; Ana Isabel Vitas; Miguel Angel Campanero; Guiomar Pérez; David Gonzalez; María J Blanco-Prieto
Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.
Expert opinion on drug delivery 2007;4(6):677-88.
2007: Sara Gómez; Carlos Gamazo; Beatriz San Roman; Marta Ferrer; María L Sanz; Juan M Irache
Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens.
Vaccine 2007;25(29):5263-71.
2007: Javier Ochoa; Juan M Irache; Ibai Tamayo; Alexander Walz; Vito G DelVecchio; Carlos Gamazo
Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.
Vaccine 2007;25(22):4410-9.
2007: M C Lecaroz; María J Blanco-Prieto; Miguel Angel Campanero; SALMAN Hesham; Carlos Gamazo
Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
Antimicrobial agents and chemotherapy 2007;51(4):1185-90.
2007: S Segura; Carlos Gamazo; Juan M Irache; Socorro Espuelas
Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.
Antimicrobial agents and chemotherapy 2007;51(4):1310-4.
2007: B S Roman; Socorro Espuelas; S Gómez; Carlos Gamazo; María L Sanz; Marta Ferrer; Juan M Irache
Intradermal immunization with ovalbumin-loaded poly-epsilon-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2007;37(2):287-95.
2006: Maite Estevan; Juan M Irache; María Jesús Grilló; José María Blasco; Carlos Gamazo
Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice.
Veterinary microbiology 2006;118(1-2):124-32.
2006: Concepcion Lecaroz; Carlos Gamazo; María Jesús Renedo; María J Blanco-Prieto
Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.
Journal of microencapsulation 2006;23(7):782-92.
2006: Carlos Gamazo; María Concepción Lecároz; Sandra Prior; Ana Isabel Vitas; Miguel Angel Campanero; Juan M Irache; María J Blanco-Prieto
Chemical and biological factors in the control of Brucella and brucellosis.
Current drug delivery 2006;3(4):359-65.
2006: Concepcion Lecaroz; Carlos Gamazo; María J Blanco-Prieto
Nanocarriers with gentamicin to treat intracellular pathogens.
Journal of nanoscience and nanotechnology 2006;6(9-10):3296-302.
2006: Sara Gómez; Carlos Gamazo; Beatriz San Roman; Christine Vauthier; Marta Ferrer; Juan M Irachel
Development of a novel vaccine delivery system based on Gantrez nanoparticles.
Journal of nanoscience and nanotechnology 2006;6(9-10):3283-9.
2006: SALMAN Hesham; Carlos Gamazo; Miguel Angel Campanero; Juan M Irache
Bioadhesive mannosylated nanoparticles for oral drug delivery.
Journal of nanoscience and nanotechnology 2006;6(9-10):3203-9.
2006: Concepción Lecároz; María J Blanco-Prieto; María A Burrell; Carlos Gamazo
Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin.
The Journal of antimicrobial chemotherapy 2006;58(3):549-56.
2006: Concepción Lecároz; Miguel Angel Campanero; Carlos Gamazo; María J Blanco-Prieto
Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method.
The Journal of antimicrobial chemotherapy 2006;58(3):557-63.
2006: Maite Estevan; Carlos Gamazo; María Jesús Grilló; Guillermo García Del Barrio; José María Blasco; Juan M Irache
Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
Vaccine 2006;24(19):4179-87.
2006: Pilar M Muñoz; Maite Estevan; Clara María Marín; M Jesús De Miguel; M Jesús Grilló; Montserrat Barberán; Juan M Irache; José María Blasco; Carlos Gamazo
Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
Vaccine 2006;24(11):1897-905.
2006: Maite Estevan; Carlos Gamazo; Gustavo González-Gaitano; Juan M Irache
Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery.
Journal of microencapsulation 2006;23(2):169-81.
2005: Cristina Latasa; Agnès Roux; Alejandro Toledo-Arana; Jean-Marc Ghigo; Carlos Gamazo; José R Penadés; Iñigo Lasa
BapA, a large secreted protein required for biofilm formation and host colonization of Salmonella enterica serovar Enteritidis.
Molecular microbiology 2005;58(5):1322-39.
2005: SALMAN Hesham; Carlos Gamazo; Miguel Angel Campanero; Juan M Irache
Salmonella-like bioadhesive nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2005;106(1-2):1-13.
2005: Sandra Prior; Bruno Gander; Juan M Irache; Carlos Gamazo
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
The Journal of antimicrobial chemotherapy 2005;55(6):1032-6.
2005: Krassimira Yoncheva; Sara Gómez; Miguel Angel Campanero; Carlos Gamazo; Juan M Irache
Bioadhesive properties of pegylated nanoparticles.
Expert opinion on drug delivery 2005;2(2):205-18.
2005: Javier Ochoa-Repáraz; Begoña García; Cristina Solano; Iñigo Lasa; Juan M Irache; Carlos Gamazo
Protective ability of subcellular extracts from Salmonella Enteritidis and from a rough isogenic mutant against salmonellosis in mice.
Vaccine 2005;23(12):1491-501.
2004: Begoña García; Cristina Latasa; Cristina Solano; Francisco García-del Portillo; Carlos Gamazo; Iñigo Lasa
Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation.
Molecular microbiology 2004;54(1):264-77.
2004: Sandra Prior; Bruno Gander; Concepción Lecároz; Juan M Irache; Carlos Gamazo
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
The Journal of antimicrobial chemotherapy 2004;53(6):981-8.
2004: Javier Ochoa-Repáraz; Begoña Sesma; Miguel Alvarez; M Jesús Renedo; Juan M Irache; Carlos Gamazo
Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens.
Veterinary research 2004;35(3):291-8.
2004: M Murillo; Juan M Irache; Maite Estevan; MM Goñi; José María Blasco; Carlos Gamazo
Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
International journal of pharmaceutics 2004;271(1-2):125-35.
2003: M Socorro Espuelas; Philippe Legrand; Miguel Angel Campanero; M Appel; Monique Chéron; Carlos Gamazo; Gillian Barratt; Juan M Irache
Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
The Journal of antimicrobial chemotherapy 2003;52(3):419-27.
2002: M Murillo; MM Goñi; Juan M Irache; Miguel Angel Arangoa; José María Blasco; Carlos Gamazo
Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens.
Journal of controlled release : official journal of the Controlled Release Society 2002;85(1-3):237-46.
2002: M Murillo; Carlos Gamazo; MM Goñi; Juan M Irache; María J Blanco-Príeto
Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.
International journal of pharmaceutics 2002;242(1-2):341-4.
2002: María J Blanco-Príeto; Concepcion Lecaroz; María Jesús Renedo; J Kunkova; Carlos Gamazo
In vitro evaluation of gentamicin released from microparticles.
International journal of pharmaceutics 2002;242(1-2):203-6.
2002: M Murillo; Carlos Gamazo; Juan M Irache; MM Goñi
Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity.
Journal of drug targeting 2002;10(3):211-9.
2002: Sandra Prior; Bruno Gander; Natalia Blarer; Hans Peter Merkle; Marija Luisa Subirá; Juan M Irache; Carlos Gamazo
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2002;15(2):197-207.
2002: Cristina Solano; Begoña García; Jaione Valle; Carmen Berasain; Jean-Marc Ghigo; Carlos Gamazo; Iñigo Lasa
Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose.
Molecular microbiology 2002;43(3):793-808.
2001: M A Casao; R Díaz; Antonio Orduña; Carlos Gamazo
Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies.
Journal of medical microbiology 2001;50(11):965-8.
2001: M Murillo; Socorro Espuelas; Sandra Prior; Ana Isabel Vitas; María Jesús Renedo; MM Goñi; Juan M Irache; Carlos Gamazo
[Controlled liberation of active principles by means of new galenic formulations].
Revista de medicina de la Universidad de Navarra 2001;45(4):19-34.
2001: M Murillo; María Jesús Grilló; J Reñé; Clara María Marín; Montserrat Barberán; MM Goñi; José María Blasco; Juan M Irache; Carlos Gamazo
A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice.
Vaccine 2001;19(30):4099-106.
2001: Cristina Solano; Begoña Sesma; Miguel Alvarez; Elena Urdaneta; D Garcia-Ros; A Calvo; Carlos Gamazo
Virulent strains of Salmonella enteritidis disrupt the epithelial barrier of Caco-2 and HEp-2 cells.
Archives of microbiology 2001;175(1):46-51.
2000: M A Bonafonte; Cristina Solano; Begoña Sesma; Miguel Alvarez; Luis M Montuenga; D García-Ros; Carlos Gamazo
The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis.
FEMS microbiology letters 2000;191(1):31-6.
2000: Cristina Solano; J Galindo; Begoña Sesma; Miguel Alvarez; M J Solsona; Carlos Gamazo
Enzyme-linked immunosorbent assay with a Salmonella enteritidis antigen for differentiating infected from vaccinated poultry.
Veterinary research 2000;31(5):491-7.
2000: Sandra Prior; Carlos Gamazo; Juan M Irache; H P Merkle; Bruno Gander
Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
International journal of pharmaceutics 2000;196(1):115-25.
1998: Cristina Solano; Begoña Sesma; Miguel Alvarez; T J Humphrey; C J Thorns; Carlos Gamazo
Discrimination of strains of Salmonella enteritidis with differing levels of virulence by an in vitro glass adherence test.
Journal of clinical microbiology 1998;36(3):674-8.
1998: M A Casao; J Leiva; Ramon Diaz; Carlos Gamazo
Anti-phosphatidylcholine antibodies in patients with brucellosis.
Journal of medical microbiology 1998;47(1):49-54.
1997: Ana Isabel Vitas; R Díaz; Carlos Gamazo
Protective effect of liposomal gentamicin against systemic acute murine brucellosis.
Chemotherapy 1997;43(3):204-10.
1996: S Domingo; Carlos Gamazo
Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections.
Journal of chemotherapy (Florence, Italy) 1996;8(1):55-8.
1996: A I Vitas; R Díaz; Carlos Gamazo
Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus.
Antimicrobial agents and chemotherapy 1996;40(1):146-51.
1995: S Domingo; I Gastearena; R Diaz; Carlos Gamazo
Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis.
Journal of chemotherapy (Florence, Italy) 1995;7 Suppl 4():29-31.
1995: S Domingo; I Gastearena; A I Vitas; Ignacio Lopez-Goñi; C Dios-Viéitez; R Díaz; Carlos Gamazo
Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
The Journal of antimicrobial chemotherapy 1995;36(4):647-56.
1995: S Domingo; R Díaz; Carlos Gamazo
Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice.
FEMS immunology and medical microbiology 1995;12(2):91-5.
1995: A I Vitas; R Diaz; Carlos Gamazo
Protective effect of Brucella outer membrane complex-bearing liposomes against experimental murine brucellosis.
FEMS microbiology letters 1995;130(2-3):231-6.
1995: C Romero; Carlos Gamazo; M Pardo; Ignacio Lopez-Goñi
Specific detection of Brucella DNA by PCR.
Journal of clinical microbiology 1995;33(3):615-7.
1994: M P Jiménez de Bagüés; Philip H Elzer; José María Blasco; Clara María Marín; Carlos Gamazo; A J Winter
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
Infection and immunity 1994;62(2):632-8.
1993: Carlos Gamazo; A I Vitas; Ignacio Lopez-Goñi; R Díaz; Ignacio Moriyón
Factors affecting detection of Brucella melitensis by BACTEC NR730, a nonradiometric system for hemocultures.
Journal of clinical microbiology 1993;31(12):3200-3.
1993: Carlos Gamazo; A I Vitas; Ignacio Moriyón; Ignacio Lopez-Goñi; R Díaz
Brucella group 3 outer membrane proteins contain a heat-modifiable protein.
FEMS microbiology letters 1993;112(2):141-6.
1993: José María Blasco; Carlos Gamazo; A J Winter; M P Jiménez de Bagüés; Clara María Marín; Montserrat Barberán; Ignacio Moriyón; B Alonso-Urmeneta; R Díaz
Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
Veterinary immunology and immunopathology 1993;37(3-4):257-70.
1992: M P Jiménez de Bagüés; Clara María Marín; José María Blasco; Ignacio Moriyón; Carlos Gamazo
An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination.
Veterinary microbiology 1992;30(2-3):233-41.
1990: José I Riezu-Boj; Ignacio Moriyón; José María Blasco; Carlos Gamazo; R Díaz
Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis.
Infection and immunity 1990;58(2):489-94.
1989: Clara María Marín; M P Jiménez de Bagués; José María Blasco; Carlos Gamazo; Ignacio Moriyón; R Díaz
Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts.
The Veterinary record 1989;125(20):504-8.
1989: Carlos Gamazo; A J Winter; Ignacio Moriyón; José I Riezu-Boj; José María Blasco; R Díaz
Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis.
Infection and immunity 1989;57(5):1419-26.
1987: Carlos Gamazo; Ignacio Moriyón
Release of outer membrane fragments by exponentially growing Brucella melitensis cells.
Infection and immunity 1987;55(3):609-15.
1987: Ignacio Moriyón; Carlos Gamazo; R Díaz
Properties of the outer membrane of Brucella.
Annales de l'Institut Pasteur. Microbiology 1987;138(1):89-91.